Corestem Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
11,026
10,368
42,478
52,012
42,635
Total Accounts Receivable
1,055
4,514
9,030
5,180
8,781
Inventories
29
172
458
607
394
Other Current Assets
255
494
323
259
1,198
Total Current Assets
12,366
15,548
52,288
58,058
53,008
Net Property, Plant & Equipment
8,301
11,441
12,559
16,964
26,138
Total Investments and Advances
530
722
1,798
1,180
1,238
Intangible Assets
5,992
5,834
5,688
5,502
5,514
Other Assets
-
-
-
711
847
Total Assets
29,984
36,960
76,059
87,137
92,022
ST Debt & Current Portion LT Debt
1,653
4,360
-
-
-
Accounts Payable
26
44
92
35
62
Income Tax Payable
103
266
571
338
61
Other Current Liabilities
1,742
7,540
4,636
4,258
5,173
Total Current Liabilities
3,523
12,209
5,298
4,632
5,296
Long-Term Debt
12,938
3,161
-
-
607
Provision for Risks & Charges
1,920
2,585
2,457
3,110
3,642
Deferred Taxes
1,967
2,471
2,635
3,325
3,987
Other Liabilities
4,889
2,399
120
237
301
Total Liabilities
24,099
21,298
8,967
9,375
11,136
Common Equity (Total)
2,378
11,532
63,039
66,727
65,601
Total Shareholders' Equity
2,378
11,532
63,039
66,727
65,601
Total Equity
5,886
15,662
67,092
77,761
80,886
Liabilities & Shareholders' Equity
29,984
36,960
76,059
87,137
92,022
Accumulated Minority Interest
3,508
4,130
4,054
11,034
15,285

About Corestem

View Profile
Address
2/F, I & C Building
Seongnam GY 13486
Korea, Republic Of
Employees -
Website http://www.corestem.com
Updated 09/14/2018
CORESTEM, Inc. engages in the development and distribution of gene therapy products. The company was founded on December 29, 2003 and is headquartered in Seoul, South Korea. .